23 results  1 of 2 

1 A Clinical Study of Peri - tarsal Dislocation
Jung Ho Rah, Jae In Ahn, Sung Hirn Joa
J Korean Orthop Assoc.1989;24(2):372-380.   Published online 2019 January 24     DOI: http://dx.doi.org/10.4055/jkoa.1989.24.2.372
      
2 Endoplasmic Reticulum Stress Induces MUC5AC and MUC5B Expression in Human Nasal Airway Epithelial Cells
Min Han Kim, Chang Hoon Bae, Yoon Seok Choi, Hyung Gyun Na, Si-Youn Song, Yong-Dae Kim
Clin Exp Otorhinolaryngol.2019;12(2):181-189.   Published online 2018 October 20     DOI: http://dx.doi.org/10.21053/ceo.2018.00493
      
3 Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Xueying Li, He Huang, Bing Xu, Hongqiang Guo, Yingcheng Lin, Sheng Ye, Jiqun Yi, Wenyu Li, Xiangyuan Wu, Wei Wang, Hongyu Zhan, Derong Xie, Jiewen Peng, Yabing Cao, Xingxiang Pu, Chengcheng Guo, Huangming Hong, Zhao Wang, Xiaojie Fang, Yong Zhou, Suxia Lin, Qing Liu, Tongyu Lin
Cancer Res Treat.2019;51(3):919-932.   Published online 2018 October 2     DOI: http://dx.doi.org/10.4143/crt.2018.230
      
4 Effectiveness of L-asparaginase-based regimens compared to anthracycline-based regimens in newly diagnosed extranodal NK/T-cell lymphoma, nasal type: a single Mexican center experience
AL A. Ávila Milord, María M. Aguilar Hernández, Roberta Demichelis Gómez, Gladys P. Agreda Vásquez
Blood Res.2018;53(3):210-217.   Published online 2018 September 28     DOI: http://dx.doi.org/10.5045/br.2018.53.3.210
      
5 Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent
Naohiro Sekiguchi, Airi Hamano, Tomoko Kitagawa, Yuya Kurihara, Kenichi Ito, Miwa Kurimoto, Kozo Watanabe, Kazuhiko Hirano, Satoshi Noto, Kazuaki Yamada, Naoki Takezako
Blood Res.2018;53(2):117-122.   Published online 2018 June 25     DOI: http://dx.doi.org/10.5045/br.2018.53.2.117
      
6 Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma
Eun-Ji Choi, Jung Yong Hong, Dok Hyun Yoon, Jihoon Kang, Chan-Sik Park, Jooryung Huh, Eun Jin Chae, Yoonse Lee, Jin-Sook Ryu, Cheolwon Suh
Blood Res.2017;52(4):270-275.   Published online 2017 December 26     DOI: http://dx.doi.org/10.5045/br.2017.52.4.270
      
7 MDL-12330A potentiates TRAIL-induced apoptosis in gastric cancer cells through CHOP-mediated DR5 upregulation
Sung-Chul Lim, Song Iy Han
Korean J Physiol Pharmacol.2017;21(4):397-405.   Published online 2017 June 26     DOI: http://dx.doi.org/10.4196/kjpp.2017.21.4.397
      
8 Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
Junghoon Shin, Jeong-Ok Lee, Ji-Young Choe, Soo-Mee Bang, Jong-Seok Lee
Cancer Res Treat.2017;49(1):274-278.   Published online 2016 June 10     DOI: http://dx.doi.org/10.4143/crt.2016.076
      
9 A Case of ALK-Negative Systemic Anaplastic Large Cell Lymphoma
Hong-Seok Kim, Seung-Joo Sim, Dae-Cheol Kim, Jae-Seok Kim, Ki-Hoon Song, Ki-Ho Kim
Ann Dermatol.2004;16(3):125-131.   Published online 2016 March 14     DOI: http://dx.doi.org/10.5021/ad.2004.16.3.125
      
10 Diffuse Pulmonary Infiltration Rapidly Progressed after the Chemotherapy of a Patient with Malignant Lymphoma
Jang Won Sohn, Dong Ho Shin, Seok Chul Yang, Ho Joo Yoon, Sung Soo Park, Jung Hee Lee, Young Yul Lee, Yo Won Choi, Moom Hyang Park
Tuberc Respir Dis.1998;45(2):465-469.   Published online 2016 March 14     DOI: http://dx.doi.org/10.4046/trd.1998.45.2.465
      
11 Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth
Eun Ju Lee, Ki Hoon Ahn, Soon Cheol Hong, Eun Hee Lee, Yong Park, Byung Soo Kim
Obstet Gynecol Sci.2014;57(6):526-529.   Published online 2014 November 20     DOI: http://dx.doi.org/10.5468/ogs.2014.57.6.526
      
12 Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
Yong Won Choi, Seong Hyun Jeong, Mi Sun Ahn, Hyun Woo Lee, Seok Yun Kang, Jin-Hyuk Choi, U Ram Jin, Joon Seong Park
J Korean Med Sci.2014;29(11):1493-1500.   Published online 2014 November 4     DOI: http://dx.doi.org/10.3346/jkms.2014.29.11.1493
      
13 Comparison of Surgical Parameters and Outcomes According to the Phacoemulsification Technique
Soa Kim, Dong Ah Ko, Jae Yong Kim, Myoung Joon Kim, Hung Won Tchah
J Korean Ophthalmol Soc.2013;54(9):1353-1358.   Published online 2013 September 14     DOI: http://dx.doi.org/10.3341/jkos.2013.54.9.1353
      
14 Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry
Hyeon Gyu Yi, Jin Seok Kim, Cheolwon Suh, Won Seog Kim, Jae-Yong Kwak, Jong-Seok Lee, Yang Soo Kim, Young Don Joo, Yoo Hong Min, Hong Ghi Lee, Sung-Soo Yoon, Jong-Ho Won, Seonyang Park, Hugh Chul Kim, Chul Soo Kim
Blood Res.2013;48(2):115-120.   Published online 2013 June 25     DOI: http://dx.doi.org/10.5045/br.2013.48.2.115
      
15 A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas
Jeong Eun Kim, Dok Hyun Yoon, Geundoo Jang, Dae Ho Lee, Shin Kim, Chan-Sik Park, Jooryung Huh, Won Seog Kim, Jinny Park, Jae Hoon Lee, Soon Il Lee, Cheolwon Suh
Korean J Hematol.2012;47(1):53-59.   Published online 2012 March 28     DOI: http://dx.doi.org/10.5045/kjh.2012.47.1.53
      
16 Primary cutaneous B-cell lymphoblastic lymphoma in an elderly man
Su-Yeon Cho, Seung-Sook Lee, Dae Hyun Back, Kyung Ah Lim, Ye Rim Lee, Hye Jin Kang
Korean J Hematol.2011;46(4):283-286.   Published online 2011 December 27     DOI: http://dx.doi.org/10.5045/kjh.2011.46.4.283
      
17 Prognostic Value of Immunohistochemical Biomarkers at Different Cut-off Values in Patients with Diffuse Large B-cell Lymphoma Treated with CHOP Chemotherapy
Sukjoong Oh, Dong Hoe Koo, Cheolwon Suh, Shin Kim, Bong Hee Park, Joon Kang, Jooryung Huh
J Korean Med Sci.2011;26(12):1556-1562.   Published online 2011 November 29     DOI: http://dx.doi.org/10.3346/jkms.2011.26.12.1556
      
18 Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
Geundoo Jang, Dok Hyun Yoon, Shin Kim, Dae Ho Lee, Sang-wook Lee, Jooryung Huh, Cheolwon Suh
Korean J Hematol.2011;46(2):103-110.   Published online 2011 June 21     DOI: http://dx.doi.org/10.5045/kjh.2011.46.2.103
      
19 A Case of Primary Adrenal Diffuse Large B-cell Lymphoma Achieving Complete Remission with Rituximab-CHOP Chemotherapy
Kyung Min Kim, Dok Hyun Yoon, Seung Geun Lee, Sung Nam Lim, Lyu Jin Sug, Jooryung Huh, Cheolwon Suh
J Korean Med Sci.2009;24(3):525-528.   Published online 2009 June 16     DOI: http://dx.doi.org/10.3346/jkms.2009.24.3.525
      
20 Treatment Outcomes with CHOP Chemotherapy in Adult Patients with Hemophagocytic Lymphohistiocytosis
Ho-Jin Shin, Joo Seop Chung, Je-Jung Lee, Sang Kyun Sohn, Young Jin Choi, Yeo-Kyeoung Kim, Deok-Hwan Yang, Hyeoung-Joon Kim, Jong Gwang Kim, Young Don Joo, Won Sik Lee, Chang-Hak Sohn, Eun Yup Lee, Goon Jae Cho
J Korean Med Sci.2008;23(3):439-444.   Published online 2008 June 20     DOI: http://dx.doi.org/10.3346/jkms.2008.23.3.439
      

 1 of 2